187 related articles for article (PubMed ID: 33872411)
21. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3.
Shailesh H; Siveen KS; Sif S
J Cell Mol Med; 2021 Feb; 25(3):1583-1600. PubMed ID: 33462997
[TBL] [Abstract][Full Text] [Related]
22. The Structural Effects of Phosphorylation of Protein Arginine Methyltransferase 5 on Its Binding to Histone H4.
Börzsei R; Bayarsaikhan B; Zsidó BZ; Lontay B; Hetényi C
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232624
[TBL] [Abstract][Full Text] [Related]
23. Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificity.
Ho MC; Wilczek C; Bonanno JB; Xing L; Seznec J; Matsui T; Carter LG; Onikubo T; Kumar PR; Chan MK; Brenowitz M; Cheng RH; Reimer U; Almo SC; Shechter D
PLoS One; 2013; 8(2):e57008. PubMed ID: 23451136
[TBL] [Abstract][Full Text] [Related]
24. Sulforaphane regulates the proliferation of leukemia stem-like cells via Sonic Hedgehog signaling pathway.
Wang F; Huang X; Sun Y; Li Z; Sun R; Zhao T; Wang M; Yan C; Liu P
Eur J Pharmacol; 2022 Mar; 919():174824. PubMed ID: 35157913
[TBL] [Abstract][Full Text] [Related]
25. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
[TBL] [Abstract][Full Text] [Related]
26. PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach.
Barbarino M; Cesari D; Bottaro M; Luzzi L; Namagerdi A; Bertolino FM; Bellan C; Proietti F; Somma P; Micheli M; de Santi MM; Guazzo R; Mutti L; Pirtoli L; Paladini P; Indovina P; Giordano A
J Cell Mol Med; 2020 May; 24(10):5565-5577. PubMed ID: 32301278
[TBL] [Abstract][Full Text] [Related]
27. Ribavirin inhibits colorectal cancer growth by downregulating PRMT5 expression and H3R8me2s and H4R3me2s accumulation.
Ge S; Zhang Q; Chen Y; Tian Y; Yang R; Chen X; Li F; Zhang B
Toxicol Appl Pharmacol; 2021 Mar; 415():115450. PubMed ID: 33577917
[TBL] [Abstract][Full Text] [Related]
28. PRMT5 confers lipid metabolism reprogramming, tumour growth and metastasis depending on the SIRT7-mediated desuccinylation of PRMT5 K387 in tumours.
Yuan HF; Zhao M; Zhao LN; Yun HL; Yang G; Geng Y; Wang YF; Zheng W; Yuan Y; Song TQ; Niu JQ; Zhang XD
Acta Pharmacol Sin; 2022 Sep; 43(9):2373-2385. PubMed ID: 35046516
[TBL] [Abstract][Full Text] [Related]
29. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
30. PRMT1 loss sensitizes cells to PRMT5 inhibition.
Gao G; Zhang L; Villarreal OD; He W; Su D; Bedford E; Moh P; Shen J; Shi X; Bedford MT; Xu H
Nucleic Acids Res; 2019 Jun; 47(10):5038-5048. PubMed ID: 30916320
[TBL] [Abstract][Full Text] [Related]
31. The Proteins Interacting with Prmt5 in Medaka (Oryzias latipes) Identified by Yeast Two-Hybridization.
Shen H; Zhang X; Al Hafiz MA; Liang X; Yao Q; Guo M; Xu G; Zhong X; Zhou Q; Zhao H
Protein Pept Lett; 2020; 27(10):971-978. PubMed ID: 32370700
[TBL] [Abstract][Full Text] [Related]
32. Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin.
Cai S; Wang P; Xie T; Li Z; Li J; Lan R; Ding Y; Lu J; Ye J; Wang J; Li Z; Liu P
Pharmacol Res; 2020 Nov; 161():105104. PubMed ID: 32739429
[TBL] [Abstract][Full Text] [Related]
33. Sulforaphane inhibits thyroid cancer cell growth and invasiveness through the reactive oxygen species-dependent pathway.
Wang L; Tian Z; Yang Q; Li H; Guan H; Shi B; Hou P; Ji M
Oncotarget; 2015 Sep; 6(28):25917-31. PubMed ID: 26312762
[TBL] [Abstract][Full Text] [Related]
34. Sulforaphane suppresses the viability and metastasis, and promotes the apoptosis of bladder cancer cells by inhibiting the expression of FAT‑1.
Wang F; Liu P; An H; Zhang Y
Int J Mol Med; 2020 Sep; 46(3):1085-1095. PubMed ID: 32705150
[TBL] [Abstract][Full Text] [Related]
35. PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression.
Jiang Y; Yuan Y; Chen M; Li S; Bai J; Zhang Y; Sun Y; Wang G; Xu H; Wang Z; Zheng Y; Nie H
Theranostics; 2021; 11(18):9162-9176. PubMed ID: 34522232
[No Abstract] [Full Text] [Related]
36. Protein arginine methyltransferase Prmt5-Mep50 methylates histones H2A and H4 and the histone chaperone nucleoplasmin in Xenopus laevis eggs.
Wilczek C; Chitta R; Woo E; Shabanowitz J; Chait BT; Hunt DF; Shechter D
J Biol Chem; 2011 Dec; 286(49):42221-42231. PubMed ID: 22009756
[TBL] [Abstract][Full Text] [Related]
37. Biochemical Investigation of the Interaction of pICln, RioK1 and COPR5 with the PRMT5-MEP50 Complex.
Krzyzanowski A; Gasper R; Adihou H; Hart P'; Waldmann H
Chembiochem; 2021 Jun; 22(11):1908-1914. PubMed ID: 33624332
[TBL] [Abstract][Full Text] [Related]
38. Crystal structure of the human PRMT5:MEP50 complex.
Antonysamy S; Bonday Z; Campbell RM; Doyle B; Druzina Z; Gheyi T; Han B; Jungheim LN; Qian Y; Rauch C; Russell M; Sauder JM; Wasserman SR; Weichert K; Willard FS; Zhang A; Emtage S
Proc Natl Acad Sci U S A; 2012 Oct; 109(44):17960-5. PubMed ID: 23071334
[TBL] [Abstract][Full Text] [Related]
39. Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity.
Rorke EA; Adhikary G; Szmacinski H; Lakowicz JR; Weber DJ; Godoy-Ruiz R; Puranik P; Keillor JW; Gates EWJ; Eckert RL
Mol Carcinog; 2022 Jan; 61(1):19-32. PubMed ID: 34610184
[TBL] [Abstract][Full Text] [Related]
40. Development of Macrocyclic PRMT5-Adaptor Protein Interaction Inhibitors.
Krzyzanowski A; Esser LM; Willaume A; Prudent R; Peter C; 't Hart P; Waldmann H
J Med Chem; 2022 Nov; 65(22):15300-15311. PubMed ID: 36378254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
